Literature DB >> 24832134

Antioxidant effect of 0.2% xanthan gum in ocular surface corneal epithelial cells.

Carla Amico1, Tatiana Tornetta, Christian Scifo, Anna Rita Blanco.   

Abstract

PURPOSE: Oxidative damage and inflammation are expected to be involved in age-related functional decline of lachrymal gland, that induces lachrymal dysfunction; this resulting in dry eye disease. Therefore, we investigated the potential antioxidant effect of 0.2% xanthan gum (XNT) in human corneal epithelial cells (HCE), in comparison with other widely used tear substitute polymers, such as 0.2% hydroxyethylcellulose (HEC), 0.2% hyaluronic acid (HA) and 0.5% carboxymethylcellulose (CMC).
METHODS: Subconfluent (80%) HCE (Human Corneal Epithelial) cultures were treated with the different polysaccharides at the above reported concentrations. The effect of every polymer was investigated with and without 0.5 mM H2O2 In detail, hydrogen peroxide was added 1 hour after the addition of polysaccharides. Twelve hours later, reactive oxygen species (ROS) production (dichlorofluorescein diacetate spectrofluorimetric test) was assessed and their values were normalized versus protein content. Morphological analysis was performed by optical microscopy.
RESULTS: No morphological differences in HCE compared to control cells (CTRL, cells treated with the buffer used for polymer solubilization) were observed in any of the tested polymers, whereas, in the presence of 0.5 mM H2O2 HCE clearly showed signs of cytotoxicity. Polymers did protect cultures from oxidative stress with XNT>HA = HEC>CMC, as evidenced by microscopic analysis. These results were confirmed from ROS measurements, which showed XNT as the only polysaccharide to restore the levels of ROS comparable to CTRL, in presence of H2O2.
CONCLUSIONS: 0.2% xanthan gum was able to protect HCE by oxidative stress, bringing the ROS level down to CTRL values. Considering that in dry eye syndrome oxidative stress sustains inflammation and apoptotic cell death, the use of xanthan gum in ophthalmic preparations could be beneficial.

Entities:  

Keywords:  Antioxidant effect; dry-eye; human corneal epithelial; oxidative stress; xanthan gum

Mesh:

Substances:

Year:  2014        PMID: 24832134     DOI: 10.3109/02713683.2014.914542

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  5 in total

1.  Histopathological changes on the ocular surface of New Zealand white rabbits after instillation of a fixed combination of 0.09 % xanthan gum and 0.1 % chondroitin sulfate.

Authors:  Angélica Y Contreras-Rubio; Leopoldo Baiza-Durán; Oscar Olvera-Montaño; Mónica Miranda-Robles; José Bonilla-García; Arieh Mercado-Sesma
Journal:  Int Ophthalmol       Date:  2016-02-27       Impact factor: 2.031

2.  Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.

Authors:  Ana L Pérez-Balbuena; Juan C Ochoa-Tabares; Sandra Belalcazar-Rey; Cristian Urzúa-Salinas; Laura R Saucedo-Rodríguez; Regina Velasco-Ramos; Raúl G Suárez-Sánchez; Adolfo D Rodríguez-Carrizalez; Aldo A Oregón-Miranda
Journal:  BMC Ophthalmol       Date:  2016-09-20       Impact factor: 2.209

Review 3.  Xanthan gum derivatives: review of synthesis, properties and diverse applications.

Authors:  Jwala Patel; Biswajit Maji; N S Hari Narayana Moorthy; Sabyasachi Maiti
Journal:  RSC Adv       Date:  2020-07-21       Impact factor: 4.036

4.  Therapeutic Efficacy of Topically Applied Antioxidant Medicinal Plant Extracts in a Mouse Model of Experimental Dry Eye.

Authors:  Won Choi; Jee Bum Lee; Lian Cui; Ying Li; Zhengri Li; Ji Suk Choi; Hyo Seok Lee; Kyung Chul Yoon
Journal:  Oxid Med Cell Longev       Date:  2016-05-26       Impact factor: 6.543

5.  Experimental and Clinical Applications of Chamaecyparis obtusa Extracts in Dry Eye Disease.

Authors:  Lian Cui; Hyo Seok Lee; Ying Li; Joo-Hee Choi; Je-Jung Yun; Ji Eun Jung; Won Choi; Kyung Chul Yoon
Journal:  Oxid Med Cell Longev       Date:  2017-12-26       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.